Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Published:2013-01-25 Issue:5 Volume:15 Page:432-440
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Kaku K.¹,Inoue S.²,Matsuoka O.³,Kiyosue A.⁴,Azuma H.⁵,Hayashi N.⁶,Tokudome T.⁷,Langkilde A. M.⁸,Parikh S.⁹

Affiliation:

1. Department of Internal Medicine, Division of Diabetes, Endocrinology and Metabolism; Kawasaki Medical School; Okayama; Japan

2. Medical Corporation Heishinkai OCROM Clinic; Osaka; Japan

3. Medical Corporation Heishinkai ToCROM Clinic; Tokyo; Japan

4. Tokyo-Eki Center-Building Clinic; Tokyo; Japan

5. Yaesu Sakura Dori Clinic; Tokyo; Japan

6. R&D, AstraZeneca K.K.; Osaka; Japan

7. R&D, Bristol-Myers K.K.; Tokyo; Japan

8. AstraZeneca R&D; Mölndal; Sweden

9. AstraZeneca R&D; Wilmington; DE; USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12047/fullpdf

Reference22 articles.

1. Islet beta cell failure in type 2 diabetes;Prentki;J Clin Invest,2006

2. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

3. State of diabetes care in the United States;Blonde;Am J Manag Care,2007

4. SGLT2 inhibition--a novel strategy for diabetes treatment;Chao;Nat Rev Drug Discov,2010

5. Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes;List;Diabetes Care,2009

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis;The Journal of Clinical Pharmacology;2024-08

2. Dapagliflozin: A new hope for the therapeutic treatment of type 2 diabetes mellitus;European Journal of Medicinal Chemistry Reports;2024-08

3. Selective sodium-glucose cotransporter-2 inhibitors in the improvement of hemoglobin and hematocrit in patients with type 2 diabetes mellitus: a network meta-analysis;Frontiers in Endocrinology;2024-02-01

4. Comparative safety of different recommended doses of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2023-11-10

5. Adverse events and drug–drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure;Expert Review of Cardiovascular Therapy;2023-11-02